Xconomy National

Archives

by in

Entry	Author	Date	Location
Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011	Arlene Weintraub	12/27/11	New York
EnVivo Posts Positive Trial of Schizophrenia Drug	Arlene Weintraub	12/05/11	Boston
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2)	Luke Timmerman	11/22/11	National
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes	Arlene Weintraub	11/10/11	New York
Raising Funds: AnaptysBio, Sonexa, Eclipse, NextDx, Naviscan	Bruce V. Bigelow	10/18/11	San Diego
Integrated Diagnostics, Leroy Hood’s Latest Startup, Pockets $10M After Hitting Early Goals	Luke Timmerman	07/22/10	Seattle
Consumer Genetics Needs More Transparency, Not Excessive Regulation	Daniel Vorhaus	06/23/10	National
Quanterix Uses Fiber Optics to Find Cancer Protein, Nears New Funding Round	Ryan McBride	05/27/10	Boston
New England’s Lucky Seven: Under the Radar Startup Financings in April	Erin Kutz	05/25/10	Boston
Avalon Raising New Fund, Althea Technologies Gets Altus Assets, Trancon Pharmaceuticals Nabs Financing, & More San Diego Life Sciences News	Denise Gellene	05/06/10	San Diego
Lee Hood’s Startup for Personalized Medicine, Integrated Diagnostics, Hires First CEO	Luke Timmerman	03/29/10	Seattle
San Diego’s Acadia Pharmaceuticals Updates Plans for Experimental Parkinson’s Drug	Denise Gellene	03/10/10	San Diego
Genomic Advances of the 2000s Will Demand an Informatics Revolution in the 2010s	Eric Schadt	01/14/10	National
Novartis Parts Ways with Idera Pharma	Ryan McBride	11/25/09	Boston
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes	Ryan McBride	10/14/09	Boston
Epix Pharma Shuts Down	Luke Timmerman	07/21/09	Boston
Zenobia Therapeutics, Inspired by Warrior Queen, Focuses on Developing Drug for Parkinson’s Disease	Bruce V. Bigelow	04/22/09	San Diego
Epix Pharma Halves Workforce	Ryan McBride	03/12/09	Boston
TheraGenetics Bought by Avacta	Luke Timmerman	01/29/09	Boston
Idera and Merck Extend R&D Deal	Ryan McBride	11/20/08	Boston
Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker	Ryan McBride	10/31/08	Boston
Epix Cutting 23 Percent of Workers	Ryan McBride	10/23/08	Boston
Page 1 of 1